Christopher Klipstein, MD, has won over 25 teaching awards, been a role model for thousands of medical students and has transformed the Hospital, Interventional and Surgical Care (HISC) course, also known as the Medicine Clerkship. As he turns the page on his 20-year run as clerkship director, he feels lucky to have landed what he … Read more

An independent expert advisory committee recommended 21-0 that the FDA grant emergency use authorization for a fourth COVID-19 vaccine, made by Novavax. We sit down with Cindy Gay, MD, MPH, Associate Professor of Medicine in the Division of Infectious Diseases at the UNC School of Medicine to discuss the Novavax data, its effectiveness, and how … Read more

Outbreaks of hepatitis A, a highly contagious viral infection involving the liver, have been on the rise since 2016. What initially began as outbreaks in a handful of states has since led to ongoing or recent hepatitis A outbreaks in 33 states across the country. Patients under the care of the Veterans Health Administration have … Read more

COVID-19, a communicable disease caused by the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), is a relatively new pandemic in the public’s eye, but it is only one of the many infectious diseases that epidemiologists like David J. Weber, MD, MPH, are continually facing. “I was at UNC for the onset of the HIV pandemic, 2001 … Read more

Tessa Andermann, MD, MPH, assistant professor in the division of infectious diseases, has received a pilot award from the Center for Gastrointestinal Biology and Disease (CGBD) for the study “Investigating the role of secondary bile acid derivatives in Th17-mediated disease: A pilot study of multiple myeloma and treatment response.” Dr. Andermann presented the proposed study … Read more

Dr. Katie Allen is an assistant professor in the Division of General Medicine and Clinical Epidemiology. Her research and clinical interests include medical education, Women’s Health, MOUD (medication for Opioid Use Disorder), and underserved populations. Dr. Allen believes it is imperative that patients understand their disease processes, and I strive to teach patients about disease in a way that they can comprehend.

Dr. Samuel R. Wilson is an assistant professor of medicine in the Division of Hematology. He is interested in the management of individuals with sickle cell disease and other red blood cell disorders. Specifically, Dr. Wilson’s work is aimed at understanding the unique complications in the aging sickle cell population and figuring out ways of improving the overall health of these individuals.

If you’ve ever felt your insides twist in knots before a big speech, you know the stomach listens carefully to the brain. In fact, the entire digestive system is closely tuned to a person’s emotions and state of mind, says William E. Whitehead, PhD, a professor of medicine in the Division of Gastroenterology and Hepatology … Read more

Spencer D. Dorn, MD, MPH, MHA, a professor of medicine in the Division of Gastroenterology and Hepatology and vice chair for care innovation in the Department of Medicine, wrote this article in Harvard Business Review. Summary: The current structure of specialty care in the United States makes it less accessible, increases costs, tarnishes patients’ experiences, … Read more

John A. Batsis, MD, an associate professor in the Division of Geriatric Medicine, discussed the advantages and challenges of using telehealth and remote monitoring in obesity management with Healio. He said delivering behavioral weight loss interventions through telehealth is feasible, acceptable and efficacious. “There’s evidence that demonstrates face-to-face vs. telemedicine-based interventions for weight loss are … Read more

People with advanced cancer who communicated their symptoms weekly using an electronic survey had about a one-third better physical function and over a 15% better control of their symptoms compared to those who were evaluated less frequently via in-person clinical visits, according to findings from a multi-state study conducted at 52 community cancer clinics. The … Read more

A paper published Sunday in the New England Journal of Medicine. For the small study, all 18 patients were given dostarlimab, a checkpoint inhibitor. The results were astounding. Every patient’s cancer disappeared, undetectable by physical examination, endoscopy, PET scans, or M.R.I. scans. Dr. Hanna K. Sanoff, MD, MPH, an associate professor of medicine in the … Read more